Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Istanbul - Delayed Quote • TRY Çemas Döküm Sanayi A.S. (CEMAS.IS) Follow Compare 2.8500 -0.0900 (-3.06%) As of 11:54:19 AM GMT+3. Market Open. Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Vertex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for CEMAS.IS 1D 5D 0.71% 1M -3.72% 3M -19.26% 6M -13.64% YTD -11.49% 1Y -43.68% 5Y 386.33% All 225.86% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Related News View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations 3 Growth Stocks That Could Help Make You a Fortune Rheinmetall Annual Sales Soar to Record $10.65 Billion, But Miss Target Rheinmetall expects strong 2025 sales in Europe's 'era of rearmament' EU Hits Back as U.S. Steel and Aluminum Tariffs Take Effect Kohl's Corp (KSS) Q4 2024 Earnings Call Highlights: Navigating Sales Declines and Strategic ... Hesai Group (HSAI) Q4 2024 Earnings Call Highlights: Record Lidar Shipments and Strong ... Roche secures Zealand obesity drug candidate for up to $5.3 billion EHang Reports Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results The most popular stocks for investors in February Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity Q4 2024 Kohls Corp Earnings Call